Neurizon Therapeutics (ASX:NUZ) Other Income (Expense) : A$-2.27 Mil (TTM As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Neurizon Therapeutics Other Income (Expense)?

Neurizon Therapeutics's other income expense for the Neurizon Therapeutics's pretax income for the six months ended in Dec. 2023 was A$0.78 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2023 was A$-2.27 Mil.

Neurizon Therapeutics Other Income (Expense) Historical Data

The historical data trend for Neurizon Therapeutics's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurizon Therapeutics Other Income (Expense) Chart

Neurizon Therapeutics Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Other Income (Expense)

Get a 7-Day Free Trial

0.92

1.52

1.13

-2.51

-2.27

Neurizon Therapeutics Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Income (Expense)	Get a 7-Day Free Trial															1.09	1.09	-3.60	0.78	-3.05

Neurizon Therapeutics Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-2.27 Mil.

Neurizon Therapeutics (ASX:NUZ) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Neurizon Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurizon Therapeutics Ltd (ASX:NUZ) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

ECQ0:Germany

Address

96-100 Albert Road, Level 4, South Melbourne, Melbourne, VIC, AUS, 3205

Website

https://www.neurizon.com

Neurizon Therapeutics Ltd is a clinical-stage biotech company that develops drug discovery intellectual property for the treatment of different types of neurodegenerative diseases. Its product pipeline is NUZ-001 (S-Monepantel).

Neurizon Therapeutics Headlines

No Headlines